No, it's not over
New Omicron subvariants are headed our way
I was talking to a neighbor the other day about COVID, and he said with vehemence he wasn't getting the new booster. He'd already had COVID twice, despite being vaccinated with the original two shots in 2021. Since COVID hadn't killed him, he said, why bother with more shots? I reminded him that more than 1 million Americans have died of COVID, and that boosters have been proven to dramatically reduce the risk of serious illness. That led him to launch into a riff on "Fauci" laced with conspiracy theories; if that damn Fauci wanted him to get boosted, well, hell, forget it. These views, of course, are shared by tens of millions of people who've absorbed the same deluge of disinformation, and who've bought into the deadly notion that the other tribe gets shots, and ours doesn't. Besides, the pandemic is over, isn't it?
Sorry, but it isn't. COVID deaths and hospitalizations have fallen dramatically, thanks to the immunity produced by hundreds of millions of vaccinations and tens of millions of COVID infections over the past year. But immunity from infection and shots wanes after four to six months, and every winter, indoor gatherings fuel surges of infectious disease. A new swarm of subvariants has evolved to evade immunity, and are spreading rapidly; hospitals in the U.K., Europe, and Singapore are filling up with COVID cases. One of the new subvariants, BQ.1, already makes up 10 percent of new cases in the U.S., according to the CDC. A substantial portion of the millions who may be infected in coming months may develop long COVID — especially those who are unvaccinated or get COVID multiple times. Fortunately, the new "bivalent" booster will help shield people from serious illness, death, and long COVID. But so far, only about 7 percent of 209 million eligible Americans have gotten the new booster, out of COVID fatigue, tribal loyalty, or not knowing it's available. Don't roll the COVID dice. Go get a booster.
This is the editor's letter in the current issue of The Week magazine.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
William Falk is editor-in-chief of The Week, and has held that role since the magazine's first issue in 2001. He has previously been a reporter, columnist, and editor at the Gannett Westchester Newspapers and at Newsday, where he was part of two reporting teams that won Pulitzer Prizes.
-
Today's political cartoons - December 21, 2024
Cartoons Saturday's cartoons - losing it, pedal to the metal, and more
By The Week US Published
-
Three fun, festive activities to make the magic happen this Christmas Day
Inspire your children to help set the table, stage a pantomime and write thank-you letters this Christmas!
By The Week Junior Published
-
The best books of 2024 to give this Christmas
The Week Recommends From Percival Everett to Rachel Clarke these are the critics' favourite books from 2024
By The Week UK Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
Should we be worried about declining birth rates?
Talking Points Baby boom or bust
By Devika Rao, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Last updated
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Are men the problem with male contraception?
Talking Points Science could now offer contraceptive gels and pills for men, but questions remain over trials, and men's responsibility
By Chas Newkey-Burden, The Week UK Published